Fujifilm Biotechnologies, a world leading contract development and manufacturing organisation (CDMO) for biologics, vacc...
Vetter, one of the world's leading pharmaceutical service providers for the production of injectable drugs, has confirme...
WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio I...
US-based Rakuten Medical, Inc. and South Korea's Lotte Biologics have signed a biopharmaceutical contract manufacturing ...
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...
How would KBI Biopharma highlight its achievements in 2025? Which key projects strengthened the company’s global C...
Fujifilm Corporation has announced the completion of one of Japan’s largest bio CDMO facilities (the new plan...
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and...
South Korea-based Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has announced...
What were the key highlights at Sygnature Discovery in 2025? Please elaborate upon the company's plans for 2026. Despit...
With the CDMO segment seeing rapid growth, how would you describe the changing profile of your clients, and how is Teiji...
Australia’s first and only clinical and commercial-scale viral vector Contract Development and Manufacturing Organ...
South Korea-based SK pharmteco and LOTTE BIOLOGICS have signed a Letter of Intent (LOI) for a strategic collaboration to...
NEOM, the sustainable region taking shape in northwest Saudi Arabia, has signed a strategic memorandum of understanding ...
South Korea-based Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has unveiled ...
Germany-based Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) ...
South Korea-based Celltrion has signed an agreement with Eli Lilly to acquire a biopharmaceutical drug substance (DS) ma...
China's WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has ann...
Fujifilm Biotechnologies has announced the opening of its manufacturing site in Holly Springs, North Carolina, US. The n...
UK-based eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Thailand's Si...
Taiwan-based EirGenix has announced a new milestone in collaboration with Merck. What began as a trusted supplier–...
Celltrion Pharm, a South Korean biopharmaceutical firm, has inked a strategic trilateral agreement with a multinational ...
The founder and long-standing CEO of PlasmidFactory GmbH, Dr. Martin Schleef, was honored in Düsseldorf with the In...
Strides Pharma Science has announced that its step-down, wholly owned subsidiary, Strides Pharma Global Pte. Limited, Si...
ChemPartner, a leading global Contract Research Organization (CRO) and Contract Development and Manufacturing Organizati...
China's BioDlink has announced that its Bevacizumab Injection has obtained marketing authorisation from&n...
Bionova Scientific, a full-service biologics contract development and manufacturing organization (CDMO) and subsidiary o...
WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced t...
ProBio, a leading contract development and manufacturing organization (CDMO) specializing in gene and cell therapy, ...
Australia-based contract development and manufacturing organisations Viral Vector Manufacturing Facility (VVMF) and...
Thermo Fisher Scientific Inc. has announced an expansion of their strategic partnership with Sanofi to enable additional...
South Korea-based biopharmaceutical company Samsung Bioepis has published a whitepaper titled ‘Solving the Biosimi...
Leading GMP cell CDMO I Peace, Inc., specialising in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therap...
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, ...
WuXi XDC Cayman Inc. a leading global Contract Research, Development and Manufacturing Organisation (CRDMO) focused on t...
Cell and gene therapies are reshaping the landscape of modern medicine—but bringing these transformative treatment...
WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRDMO) in China, has an...
What were the key drivers behind Syngene’s transition from the Clinical Development department to a more integrate...
Vetter, a globally operating Contract Development and Manufacturing Organisation (CDMO), recently celebrated the start o...
AGC Biologics will commence cell therapy process development and clinical manufacturing services on July 1, 2025, at AGC...
EVA Pharma, one of the leading pharmaceutical companies driving healthcare innovation and access across the Middle East ...
H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio Holdings, Inc. has announced that Fujirebio Diagnos...
Lotte Biologics, Axcelead Drug Discovery Partners, Inc., and Kanaph Therapeutics Inc. have signed a tripartite Memorandu...
Enzene, a pioneer in fully-connected continuous biologics manufacturing technology, announced that ahead of the of...
South Korea-based Samsung Biologics, a leading contract development and manufacturing organisation (CDMO), has announced...
Cytiva, a Danaher company and global life sciences leader, has completed significant expansion projects in several locat...
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has kicked off c...
Japan-headquartered Fujifilm Corporation's Life Sciences Group companies, a portfolio of businesses offering products, s...
Taiwan headquartered Bora Biologics, a leading contract development and manufacturing organization (CDMO) specialis...
China-based WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has ...
Taiwan-based Bora Pharmaceuticals , a global leader in pharmaceutical manufacturing, has announced the appointment of Je...
Sanyou Biopharmaceuticals Co. and TransRecoBio Biotechnology Co. have signed a strategic cooperation agreement. The two ...
US-based AGC Biologics, a global Contract Development and Manufacturing Organisation (CDMO), has announced a multiphase ...
Merck, known as MSD outside of the United States and Canada, has announced the start of construction for a $1 billion, 4...
South Korea-based Lotte Biologics has signed a manufacturing agreement with an Asia-based biotech company for ...
BioDuro is expanding its global contract research, development and manufacturing organisation (CRDMO) network with the o...
AGC Biologics has announced a strategic decision about the large-scale single-use technology it will use at it...
The pharmaceutical sector, which is one of the highest emitters of carbon, is no exception. According to Deloitte, more ...
Xcell Biosciences Australia Pty Ltd, an Australian affiliate of the San Francisco-based instrumentation company focused ...
ENCell Co., Ltd., a South Korean biotech company specialising in advanced biopharmaceutical contract development and man...
Amaran Biotechnology Inc., a subsidiary of OBI Pharma specialising in Contract Development and Manufacturing Organizatio...
WuXi XDC Cayman Inc., a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specialisi...
Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has announced a significant exp...
Syngene International Limited, a global contract research, development, and manufacturing organization (CRDMO), has anno...
Boehringer Ingelheim’s biopharmaceutical facility in Shanghai, China, meets the conditions to participate in a reg...
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...
WuXi Biologics, a leading global contract research, development, and manufacturing organization (CRDMO...
CDMO Live has emerged as the definitive industry gathering, bringing together Europe's leading pharmaceutical outsourcin...
China-based WuXi XDC Cayman Inc., a leading global CRDMO (Contract Research, Development, and Manufacturing Organization...
Jubilant Biosys Innovative Research Services Pte Limited, Singapore (JBIRSPL), a subsidiary of Jubilant Biosys Limited, ...
Chime Biologics has a vision to make biologics more accessible and affordable. How does this vision drive your day-to-da...
At the 2025 J.P. Morgan Healthcare Conference held recently, now in its 43rd year, South Korea-based Lotte Biologics unv...
Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, has announced a s...
South Korea-based Samsung Biologics, a global contract development and manufacturing organisation (CDMO), has announced&...
Porton Pharma Solutions and Dragon Sail Pharmaceutical (Shanghai) have signed a strategic cooperation agreement in Guili...
Japan-based Shimadzu Corporation has signed an investment contract with U-Medico Inc, a contract research organisation (...
Viva Biotech Holdings Group has announced the official establishment of its new branch in Boston, US. As a glo...
VectorBuilder, a global leader in end-to-end gene delivery services, and Sartorius, a leading international partner in l...
Samsung Biologics, a global contract development and manufacturing organisation (CDMO) based in South Korea, has announc...
China-based Chime Biologics, a leading global contract development and manufacturing organisation (CDMO) that enables it...
Lonza, a global development and manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, has anno...
GenScript Biotech Corporation, a global leader in life sciences services and products, has announced the establishment o...
In a recent conversation with Ankit Kankar from BioSpectrum Asia, Yvonne Lungershausen, CEO of Avance Clinical, shared i...
Fujifilm Diosynth Biotechnologies, a world-leading contract development and manufacturing organisation (CDMO) for biolog...
MilliporeSigma, the US and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has announced a $76 million e...
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...
South Korea-based Samsung Biologics, a global contract development and manufacturing organization (CDMO), has annou...
EirGenix (HQ: Taipei, Taiwan), an established Taiwanese Contract Development and Manufacturing Organization (CDMO), spec...
Taiwan-based Bora Pharmaceuticals Co. has announced the appointment of J.D. Mowery to the newly created position of Divi...
US-headquartered SK pharmteco, a global contract development and manufacturing organisation (CDMO), has announced a majo...
Cytiva, a global life sciences leader, has opened its first Innovation Hub in Korea, located in the Songdo Bio-cluster i...
To provide flexible and innovative solutions for early development challenges commonly faced by biotech and pharmaceutic...
South Korea-based Samsung Biologics, a global contract development and manufacturing organisation (CDMO), has launched a...
Taiwan-based Bora Pharmaceuticals Co. has announced that its Board of Directors has approved a strategic investment into...
ST Pharm, a leading technology-driven RNA CDMO based in South Korea, and Belgium-based Quantoom Biosciences, a specialis...
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Or...
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, Lotte Biologics, under the leadersh...
Porton Advanced, a subsidiary of China headquartered contract development and manufacturing organisation (CDMO) Porton P...
US-based Emergent BioSolutions Inc. has entered into a definitive agreement to sell its drug product facility in Baltimo...
Vetter, a leading global contract development and manufacturing organization (CDMO), has announced its plans to move and...
